ARTICLE | Clinical News
Hemopure hemoglobin glutamer: Phase IIb/III hold
May 25, 2009 7:00 AM UTC
Biopure said FDA placed a clinical hold on the U.S. Phase IIb/III RESUS trial, which was proposed by the Naval Medical Research Center (NMRC) and designed to enroll injured civilians. In 2006, an FDA...